NCT02293655
The Effects of ADHD Medication (TEAM) Study
See it on ClinicalTrials.gov ↗109 people
33.9%
66.1%
37 womenmiddle line = equal numbers72 men
- Phase
- PHASE4
- Paid for by
- Children's Hospital Medical Center, Cincinnati
- Finished
- 2021-06-30
- Health conditions
- ADHD
- Who could join
- Anyone
- Ages
- 7 Years – 11 Years
- Average age
- Not reported
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 80.7% · More than one race 9.2% · Black / African American 7.3% · Asian 2.8% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · Not reported 0%
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 11 Years.”
- No pregnant women
Women who were pregnant could not join.
“Pregnancy: The safety of MPH use during pregnancy has not been established”
- No seizures
Women with epilepsy or past seizures were turned away.
“Organic Brain Injury: History of head trauma, neurological disorder (including epilepsy), or other disorder affecting brain function due to potential differences in neurophysiology of ADHD phenotype”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Psychiatric Medications: Current or prior use of any medication for psychological/psychiatric problems”
Study titles and rules are shown in their original English.